[1]
K. Boch, “Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris”, Acta Derm Venereol, vol. 102, p. adv00835, Dec. 2022.